|Day Low/High||12.96 / 12.98|
|52 Wk Low/High||7.65 / 10.38|
Despite the disparity this year between growth and value, my 2017 Double Net Value Portfolio is not struggling.
Jonathan Heller says this portfolio of under-followed names and what some would consider misfits is holding its own so far.
Double-Net Dividend stocks, which some would call misfits, doing OK so far.
Levi & Korsinsky, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California on behalf of current stockholders of West Marine, Inc.
Jonathan Heller reports on his Double-Net Dividend portfolio, a mix of companies trading cheaply relative to net current assets that also return cash to shareholders.
Just two months after its creation, the portfolio handily is beating the Russell 2000 Index and Russell Microcap Index.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased West Marine, Inc.
Bob Evans Farms and Kulicke & Soffa were among the first-half winners, while Ruby Tuesday and Fitbit were big disappointments.
BeiGene and Impax Laboratories were among the biotech movers in premarket trading on July 6.
BioCryst Pharmaceuticals, Omeros and Radius Health were among the were among the biotech stock movers in premarket trading on July 3.
'Double-nets' have been fertile ground for acquisitions.
Oklahoma Attorney General Mike Hunter alleged that the firms engaged in misleading marketing practices and "waged a fraudulent, decade-long marketing campaign to profit from the anguish of thousands of Oklahomans."
Shares of Paratek Pharmaceuticals, Opko Health and Endo International were among the biotech stock movers in premarket trading on June 30.
In recent trading, shares of West Marine, Inc. have crossed above the average analyst 12-month target price of $9.67, changing hands for $9.75/share.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
One might think that companies trading cheaply would not be dividend payers. But that’s not the case.
The list is dominated by retailers, of which there are four; that's unfortunate, given the pressure that sector is facing these days.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALOT, BOOM, BWA, DAR, EHTH, ESRT, ETR, FNGN, FOE, FPO, FSS, GGG, KKR, KRA, MSCC, TOT, TZOO, WMAR Downgrades: BABY, CREG, DEPO, ETH, EXPE, GNRC, SPOK, TDC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.